Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-02-22 @ 9:39 AM
Study NCT ID:
NCT02625935
Status:
COMPLETED
Last Update Posted:
2017-10-13
First Post:
2015-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
Sponsor:
NanoString Technologies, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2017-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-07
First Submit QC Date:
None
Study First Post Date:
2015-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-11
Last Update Post Date:
2017-10-13
Last Update Post Date Type:
ACTUAL